Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

被引：0
作者：
Thomas J. van Rijssen
Elon H. C. van Dijk
Paula Scholz
Robert E. MacLaren
Sascha Fauser
Susan M. Downes
Carel B. Hoyng
Camiel J. F. Boon
机构：
[1] Leiden University Medical Center,Department of Ophthalmology
[2] University Hospital of Cologne,Department of Ophthalmology
[3] Oxford University Hospitals NHS Foundation Trust,Oxford Eye Hospital, John Radcliffe Hospital
[4] West Wing,Department of Ophthalmology
[5] F. Hoffmann-La Roche,Amsterdam University Medical Centers, Academic Medical Center, Department of Ophthalmology
[6] Radboud University Medical Center,undefined
[7] University of Amsterdam,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2021年 / 259卷
关键词：
Central serous chorioretinopathy; Foveal atrophy; Photodynamic therapy; Fluorescein angiography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：905 / 910
页数：5
相关论文
共 159 条
  • [1] Gass JD(1967)Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic central serous choroidopathy Am J Ophthalmol 63 587/515-615/543
  • [2] Haimovici R(2004)Risk factors for central serous chorioretinopathy: a case-control study Ophthalmology 111 244-249
  • [3] Koh S(2018)Discrepancy in current central serous chorioretinopathy classification Br J Ophthalmol 103 737-742
  • [4] Gagnon DR(2019)Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy Ophthalmology 126 576-588
  • [5] Lehrfeld T(2019)Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 257 1419-1425
  • [6] Wellik S(2019)Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE trial report no. 3 Am J Ophthalmol 205 1-10
  • [7] Singh SR(2018)Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy Clinical ophthalmology (Auckland, NZ) 12 2167-2176
  • [8] Matet A(2019)Central serous chorioretinopathy: towards an evidence-based treatment guideline Prog Retin Eye Res 73 100770-118
  • [9] van Dijk EHC(2015)Central serous chorioretinopathy: recent findings and new physiopathology hypothesis Prog Retin Eye Res 48 82-1555
  • [10] Daruich A(2018)Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial Ophthalmology 125 1547-793
12345678910